{{Rsnum
|rsid=7539625
|Gene=IL23R
|Chromosome=1
|position=67207082
|Orientation=plus
|GMAF=0.3352
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=IL23R
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.8 | 40.2 | 50.0
| HCB | 24.8 | 53.3 | 21.9
| JPT | 30.1 | 53.1 | 16.8
| YRI | 10.3 | 46.9 | 42.8
| ASW | 1.8 | 50.0 | 48.2
| CHB | 24.8 | 53.3 | 21.9
| CHD | 28.4 | 55.0 | 16.5
| GIH | 32.7 | 49.5 | 17.8
| LWK | 8.2 | 37.3 | 54.5
| MEX | 1.8 | 35.1 | 63.2
| MKK | 8.3 | 43.6 | 48.1
| TSI | 7.8 | 52.9 | 39.2
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs7539625
|Name_s=
|Gene_s=IL23R
|Feature=
|Evidence=PubMed ID:18439550
|Annotation=In a case - control study, this variant was shown to be associated with susceptibility to Crohn's Disease.
|Drugs=
|Drug Classes=
|Diseases=Crohn Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA161614200
}}

{{PMID|17804789|OA=1
}} Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.

{{PMID|18779654|OA=1
}} Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population.

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7539625
|overall_frequency_n=3219
|overall_frequency_d=10758
|overall_frequency=0.299219
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=33
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=24912586
|Title=A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}